The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

More documents

Recommendations

Info

A Clinical Guide to Supportive and Palliative Care for HIV/AIDS • Chapter 5: Constitutional Symptoms17. Oster MH, Enders SR, Samuels SJ, et al. Megestrol acetate in patients with AIDS and cachexia.Ann Intern Med 121:400-8, 1994.18. Von Roenn JH, Armstrong D, Kotler DP, et al. Megestrol acetate in patients with AIDS-related cachexia.Ann 26 Intern picas Med 121:393-9, 1994.19. Bruera E, Fainsinger RL. Clinical management of cachexia and anorexia. In Doyle D, Hanks GWC,MacDonald N, eds. Oxford Textbook of Palliative Medicine, 2nd ed. New York: Oxford University Press, 1998.20. Hollander H, Katz MH. HIV infection. In Tierney LM, McPhee SJ, Papadakis MA, eds. Current MedicalDiagnosis and Treatment 2001. New York: Lange, 2001.21. Koller E, Mann M, Malozowski S, et al. Aseptic necrosis in HIV seropositive patients: a possible etiologic rolefor megestrol acetate. AIDS Patient Care STDS 14:405-10, 2000.22. Sullivan PS, Dworkin MS, Jones JL, Hooper WC. Epidemiology of thrombosis in HIV-infected individuals.The adult/adolescent spectrum of HIV disease project. AIDS 14:321-4, 2000.23. Padmanabhan S, Rosenberg AS. Cushing’s syndrome induced by megestrol acetate in a patient with AIDS.Clin Infect Dis 27:217-8, 1998.24. Gonzalez del Valle L, Herrero Ambrosio A, Martinez Hernandez P, et al. Hyperglycemia induced by megestrolacetate in a patient with AIDS. Ann Pharmacother 30:1113-4, 1996.25. Engelson ES, Pi-Sunyer FX, Kotler DP. Effects of megestrol acetate therapy on body composition andcirculating testosterone concentrations in patients with AIDS. AIDS 9:1107-8, 1995.26. Leinung MC, Liporace R, Miller CH. Induction of adrenal suppression by megestrol acetate in patients withAIDS. Ann Intern Med 122: 843-5, 1995.27. Shevitz A, Knox TA. Nutrition in the era of highly active antiretroviral therapy. Clin Infect Dis 32:1768-75,2001.28. Neuenschwander H, Bruera E. Asthenia. In Doyle D, Hanks GWC, MacDonald N, eds. Oxford Textbook ofPalliative Medicine, 2nd ed. New York: Oxford University Press, 1998.29. Beal JE, Olson R, Laubenstein L, et al. Dronabinol as a treatment for anorexia associated with weight loss inpatients with AIDS. J Pain Symptom Manage 10:89-97, 1995.30. Timpone JG, Wright DJ, Li N, et al. The safety and pharmacokinetics of single-agent and combinationtherapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome.AIDS Res Hum Retroviruses 13:305-15, 1997.31. Grinspoon S, Corcoran C, Parlman K, et al. Effects of testosterone and progressive resistance training ineugonadal men with AIDS wasting: a randomized, controlled trial. Ann Intern Med 133:348-55, 2000.32. Best TR, Jenkins JK, Murphy FY, et al. Persistent adrenal insufficiency secondary to low-dose ketoconazoletherapy. Am J Med 82:676-80, 1987.33. Mylonakis E, Koutkia P, Grinspoon S. Diagnosis and treatment of androgen deficiency in humanimmunodeficiency virus-infected men and women. Clin Infect Dis 33:857-64, 2001.34. Rabkin JG, Wagner GJ, Rabkin R. A double-blind, placebo-controlled trial of testosterone therapyfor HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry 57:141-7, 2000.35. Miller K, Corcoran C, Armstrong C, et al. Transdermal testosterone administration in women with acquiredimmunodeficiency syndrome wasting: a pilot study. J Clin Endocrinol Metab 83:2717-25, 199836. Berger JR, Pall L, Hall CD, et al. Oxandrolone in AIDS-wasting myopathy. AIDS 10:1657-62, 1996.37. Strawford A, Barbieri, T, Van Loan, M, et al. Resistance exercise and supraphysiologic androgen therapy ineugonadal men with HIV-related weight loss: A randomized controlled trial. JAMA 281:1282-90, 1999.38. Batterham MJ, Garsia R. A comparison of megestrol acetate, nandrolone decanoate and dietary counsellingfor HIV associated weight loss. Int J Andrology 24:232-40, 2001.39. Schambelan M, Mulligan K, Grunfeld C, et al. Serostim Study Group: Recombinant human growth hormonein patients with HIV-associated wasting: a randomized, placebo-controlled trial. Ann Intern Med 125:873-82,1996.132U.S. Department of Health and Human Services • Health Resources and Services Administration • HIV/AIDS Bureau
A Clinical Guide to Supportive and Palliative Care for HIV/AIDS • Chapter 5: Constitutional Symptoms40. Abbaticola M, Fisher A. Effects of recombinant human growth hormone (r-hGH) and aggressive nutritionsupport on body weight in HIV infection and concurrent opportunistic infection. Abstract presented atFourth International Conference on Nutrition and HIV Infection; April 22-26, 1997; Cannes, France.41. Nemechek 26 picas PM. Short-term human growth hormone therapy for HIV-associated wasting. AIDS Patient CareSTDS 13:391-3, 1999.42. Bartlett JG, Gallant J. 2001-2002 Medical Management of HIV Infection. Baltimore: Johns HopkinsUniversity, Division of Infectious Diseases and AIDS Services.43. Wagner JG, Rabkin JG, Rabkin R. Dextroamphetamine as a treatment for depression and low energy in AIDSpatients: a pilot study. J Psychosom Res 42:407-11, 1997.44. Krakauer EL. Palliative care. In Goroll AH, Mulley AG, eds. Primary Care Medicine: Office Evaluation andManagement of the Adult Patient, 4th ed. Philadelphia: Lippincott, 2000.45. Breitbart W, Chochinov HM, Passik S. Psychiatric aspects of palliative care. In Doyle D, Hanks GWC,MacDonald N, eds. Oxford Textbook of Palliative Medicine, 2nd ed. New York: Oxford University Press, 1998.46. Breitbart W, Rosenfeld B, Kaim M, Funesti-Esch J. A randomized, double-blind, placebo-controlled trial ofpsychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virusdisease. Arch Intern Med 161:411-20, 2001.47. Wormser GP, Horowitz H, Dworkin B. Low-dose dexamethasone as adjunctive therapy for disseminatedMycobacterium avium complex infections in AIDS patients. Antimicrob Agents Chemother 38:2215-7, 1994.48. Steven N, Pithie A, Wood M, Innes J. Corticosteroid therapy for AIDS patients with Mycobacterium aviumintracellulareinfection. AIDS 8:136-8, 1994.49. Dorman S, Heller H, Basgoz N, Sax P. Adjunctive corticosteroid therapy for patients whose treatment fordisseminated Mycobacterium avium complex infection has failed. Clin Infect Dis 26:682-6, 1998.50. Pittelkow MR, Loprinzi CL. Pruritis and sweating. In Doyle D, Hanks GWC, MacDonald N, eds. OxfordTextbook of Palliative Medicine, 2nd ed. New York: Oxford University Press, 1998.VU.S. Department of Health and Human Services • Health Resources and Services Administration • HIV/AIDS Bureau 133
Page 4 and 5:
DedicationA Clinical Guide to Suppo
Page 6 and 7:
Lynn A Jansen, RN, PhDAssistant Res
Page 9 and 10:
TABLE OF CONTENTSPart IChapter 1Cha
Page 11 and 12:
IChapter 1.26 picasHIV and Palliati
Page 13:
IA Clinical Guide to Supportive and
Page 16 and 17:
A Clinical Guide to Supportive and
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 47 and 48:
IIIChapter 3.Assessment of Physical
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92: A Clinical Guide to Supportive and
Page 93: A Clinical Guide to Supportive and
Page 145 and 146: Chapter 6.26 picasPulmonary Symptom
Page 165: A Clinical Guide to Supportive and
Page 177 and 178: Chapter 8.26 picasOral ProblemsDavi
Page 187 and 188: Chapter 9.26 picasDermatologic Prob
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Chapter 10.26 picasPsychiatric Prob
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Chapter 11.26 picas Substance Use P
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
Page 290 and 291:
Page 292 and 293:
Page 294 and 295:
Page 296 and 297:
Page 298 and 299:
Page 300 and 301:
Page 302 and 303:
Page 304 and 305:
Page 306 and 307:
Page 308 and 309:
Page 311 and 312:
Chapter 14.26 picasCulture and Care
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Chapter 15.26 picasSpecial Populati
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337:
Page 340 and 341:
Page 342 and 343:
Page 344 and 345:
Page 346 and 347:
Page 348 and 349:
Page 350 and 351:
Page 352 and 353:
Page 354 and 355:
Page 356 and 357:
Page 359 and 360:
Chapter 17.26 picasEthical IssuesLy
Page 361 and 362:
Page 363 and 364:
Page 365 and 366:
Page 367 and 368:
Page 369 and 370:
Page 371 and 372:
Page 373 and 374:
Page 375 and 376:
Chapter 18.26 picasLegal and Financ
Page 377 and 378:
Page 379 and 380:
Page 381 and 382:
Page 383 and 384:
Page 385 and 386:
Page 387 and 388:
Page 389 and 390:
Page 391 and 392:
Page 393 and 394:
Page 395 and 396:
Page 397 and 398:
Chapter 19.Palliative 26 picas Care
Page 399 and 400:
Page 401 and 402:
Page 403 and 404:
Page 405 and 406:
Page 407 and 408:
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
Page 415 and 416:
Page 417:
Page 420 and 421:
Page 422 and 423:
Page 424 and 425:
Page 426 and 427:
Page 428 and 429:
Page 430 and 431:
Page 432 and 433:
Page 434 and 435:
Page 436 and 437:
Page 438 and 439:
Page 441 and 442:
Chapter 21.26 picas Patient-Clinici
Page 443 and 444:
Page 445 and 446:
Page 447 and 448:
Page 449 and 450:
Page 451 and 452:
Page 453 and 454:
Page 455:
Page 458 and 459:
Page 460 and 461:
Page 462 and 463:
Page 464 and 465:
Page 466 and 467:
Page 468 and 469:
Page 470 and 471:
Page 472 and 473:
Page 474 and 475:
Page 476 and 477:
Page 478 and 479:
Page 480 and 481:
Page 482 and 483:
Page 484 and 485:
Page 486 and 487:
Page 489 and 490:
Chapter 23.26 picas Medical Care in
Page 491 and 492:
Page 493 and 494:
Page 495 and 496:
Page 497 and 498:
Page 499 and 500:
Page 501:
Page 504 and 505:
Page 506 and 507:
Page 508 and 509:
Page 510 and 511:
Page 512 and 513:
Page 515 and 516:
Chapter 25.26 picas Prevention of S
Page 517 and 518:
Page 519 and 520:
Page 521 and 522:
Page 523 and 524:
Page 525 and 526:
Chapter 26.26 picasResourcesMagda B
Page 527 and 528:
Page 529 and 530:
Page 531 and 532:
Page 533 and 534:
Page 535 and 536:
Page 537 and 538:
Page 539 and 540:
Page 541 and 542:
Page 543 and 544:
Page 545 and 546:
Page 547 and 548:
Page 549 and 550:
Page 551 and 552:
Page 553 and 554:
Page 555 and 556:
Page 557:
Page 560 and 561:
Page 562 and 563:
Page 564 and 565:
Page 566 and 567:
Page 568 and 569:
Page 570 and 571:
Page 572 and 573:
Page 574 and 575:
Page 576 and 577:
Page 578 and 579:
Page 580 and 581:
Page 582 and 583:
Page 584 and 585:
Page 586 and 587:
Page 588 and 589:
Page 590 and 591:
Page 592 and 593:
Page 594 and 595:
Page 596 and 597:
Page 598 and 599:
Page 600 and 601:
Page 602 and 603:
Page 604 and 605:
Page 606 and 607:
DRUGS AND THERAPIES INDEXNOTES: Ent
Page 608 and 609:
Page 610 and 611:
Page 612:
show all

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

Create successful ePaper yourself

Delete template?

Save as template?